文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

作者信息

Wilkinson Brendan L, Day Stephanie, Malins Lara R, Apostolopoulos Vasso, Payne Richard J

机构信息

School of Chemistry, The University of Sydney, New South Wales 2006, Australia.

出版信息

Angew Chem Int Ed Engl. 2011 Feb 11;50(7):1635-9. doi: 10.1002/anie.201006115. Epub 2011 Jan 7.

DOI:10.1002/anie.201006115

Abstract

摘要

相似文献

[1]

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

Angew Chem Int Ed Engl. 2011-2-11

[2]

Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.

Chemistry. 2012-10-22

[3]

Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.

Chembiochem. 2014-7-7

[4]

First self-adjuvant multicomponent potential vaccine candidates by tethering of four or eight MUC1 antigenic immunodominant PDTRP units on a calixarene platform: synthesis and biological evaluation.

Bioconjug Chem. 2013-9-16

[5]

Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.

Chemistry. 2011-4-27

[6]

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

Glycobiology. 2006-2

[7]

A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy.

J Am Chem Soc. 2012-5-17

[8]

Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.

Chemistry. 2012-12-23

[9]

Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells.

Angew Chem Int Ed Engl. 2014-1-21

[10]

Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.

Bioconjug Chem. 2008-3

引用本文的文献

[1]

Synthetic self-adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy.

MedComm (2020). 2024-2-9

[2]

Peptide Hydrogels as Immunomaterials and Their Use in Cancer Immunotherapy Delivery.

Adv Healthc Mater. 2023-10

[3]

Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen.

Chem Sci. 2023-3-1

[4]

From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.

Front Chem. 2023-1-17

[5]

Peptide-Drug Conjugates: A New Hope for Cancer Management.

Molecules. 2022-10-25

[6]

Injectable DNA Hydrogel-Based Local Drug Delivery and Immunotherapy.

Gels. 2022-6-24

[7]

Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.

RSC Adv. 2022-6-29

[8]

Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.

Chembiochem. 2022-8-17

[9]

Synthesis and functional studies of self-adjuvanting multicomponent anti-HER2 cancer vaccines.

RSC Adv. 2021-10-15

[10]

Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development.

Chem Sci. 2021-12-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索